Internal Medicine, Cardiovascular Disease · McAllen, TX
NPI
1720047806
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1801 S 5th St Ste 114
McAllen, TX, 78503
Phone (956) 362-8400
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
867 services
Medicare patients, 2024
160
Average age 75
Drug cost, 2024
$3.0M
12,884 prescriptions
Company payments, 2025
$505
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tawhid A Shuaib was code 99214 (office e&m - established), 208 times for 120 patients. In total Tawhid A Shuaib billed 867 services in 32 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 208 | 120 | $88.11 | $18K |
| 93000 Electrocardiogram | Office | 192 | 134 | $9.99 | $1,919 |
| 80061 Clinical Chemistry | Office | 92 | 81 | $12.98 | $1,194 |
| 93306 Echocardiography (TTE/TEE) | Facility | 64 | 64 | $50.25 | $3,216 |
| 93018 Electrocardiogram | Facility | 44 | 44 | $10.13 | $446 |
| 93016 Electrocardiogram | Facility | 43 | 43 | $15.17 | $652 |
| 78452 Myocardial Perfusion Scan | Facility | 34 | 34 | $54.05 | $1,838 |
| 93280 External Electrocardiographic Monitoring | Office | 29 | 21 | $24.49 | $710 |
| 93923 Duplex Scan - Extremity Arteries | Facility | 22 | 22 | $16.38 | $360 |
| 93925 Duplex Scan - Extremity Arteries | Facility | 22 | 22 | $28.47 | $626 |
| 99204 Office E&M - New | Office | 18 | 18 | $109.38 | $1,969 |
| 93880 Duplex Scan - Extracranial Arteries | Facility | 16 | 16 | $28.67 | $459 |
| 93224 Electrocardiogram | Office | 13 | 13 | $47.96 | $624 |
By year: 2022 $69K for 1,558 services; 2023 $60K for 1,407 services; 2024 $35K for 867 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80061 Clinical Chemistry | 92 | 81 | $12.98 | $1,194 |
Medicare prescription drug claims, 2024
In 2024, the drug Tawhid A Shuaib prescribed most often to Medicare patients was Metoprolol Succinate, with 1,617 prescriptions and refills. In total Tawhid A Shuaib wrote 12,884 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,617 | 4,099 | 571 | $24K |
| Atorvastatin Calcium Generic | 1,005 | 2,592 | 386 | $8,850 |
| Farxiga Dapagliflozin Propanediol | 683 | 1,364 | 230 | $732K |
| Losartan Potassium Generic | 608 | 1,539 | 223 | $5,380 |
| Spironolactone Generic | 574 | 1,418 | 221 | $4,707 |
| Furosemide Generic | 553 | 1,356 | 202 | $2,519 |
| Ezetimibe Generic | 521 | 1,443 | 213 | $11K |
| Rosuvastatin Calcium Generic | 513 | 1,304 | 205 | $6,807 |
| Eliquis Apixaban | 503 | 1,001 | 157 | $580K |
| Entresto Sacubitril/Valsartan | 412 | 783 | 115 | $510K |
| Lisinopril Generic | 407 | 1,043 | 167 | $3,043 |
| Ranolazine Er Ranolazine | 385 | 853 | 139 | $38K |
| Pentoxifylline Generic | 384 | 915 | 130 | $14K |
| Cilostazol Generic | 368 | 820 | 137 | $9,165 |
| Amlodipine Besylate Generic | 363 | 893 | 140 | $2,183 |
Brand drugs: - claims; generic drugs: 10,163 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tawhid A Shuaib $505 ($505 in general payments such as food, travel and fees) from 9 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $154.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $154 |
| Amgen Inc. AMGN | 6 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75.1 |
| Merck Sharp & Dohme LLC MRK | 3 | $65.09 |
| CVRx, Inc. CVRX | 1 | $30.43 |
| Boston Scientific Corporation BSX | 1 | $18.58 |
| Novo Nordisk Inc NVO | 1 | $18.31 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $16.6 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $15.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.